Yesterday was a big day for the people looking for liver cancer treatment new options as FDA expanded the indications of Bayer's Regorafenib (Stivarga) to include the treatment of patients with liver cancer who have until now been treated with Sorafenib.
Ads by Google
GMO Insulin Shuts Down The Pancreas In Type 2 Diabetes Escalating Patients To Type 1, But You Can Avoid It
GMO Insulin has been shown to accelerate Type 2 Diabetes to Type 1 Diabetes, a study finds.
Researchers say if you think that binge drinking is safer for your liver than regular heavy drinking than perhaps you should stop and think this over again.
People who drink three or more alcoholic beverages per day could be increasing their chances of developing liver cancer.
Nexavar becomes the first FDA-approved drug treatment therapy for patients suffering from liver cancer. Nexavar is made by Bayer Healthcare and the FDA liver cancer treatment node was announced today.
Progen Pharmaceuticals awarded to PI-88 for the prevention of tumour recurrence following curative resection of primary liver cancer and in order to commence the Phase 3 program as rapidly as possible, the Company will no longer continue with the Special Protocol Assessment process.
Adding more good news to last week's announcement that Nexavar (sorafenib) may be the first effective treatment for advanced liver cancer, researchers at the Lombardi Comprehensive Cancer Center at Georgetown University have uncovered a new molecular mechanism that may "spontaneously" cause liver cancer.
Bayer and Onyx Pharmaceuticals say Nexavar tablets significantly extended overall survival in primary liver cancer versus those taking placebo by 44 percent.